Let's Talk MRSA: 20 Frequently Asked Questions
Subscribe in ParasocialFree on the App Store for iPhone, iPad and Mac. No subscription. Once it is installed, tap this link again and the show is yours. Already have it? Open in Parasocial.
About
Designed to clarify persistent issues in serious MRSA infections that pose a threat to patient safety and add to the healthcare burden. Experts answer frequently asked questions and share their own clinical experience. This activity consists of 20 episodes that will be released weekly beginning October 4, 2010.
Also on
Recent episodes
- What are the short- and long-term challenges as well as advancements that will impact the management of patients with MRSA infections?
- How can we prevent the spread of MRSA in the hospital?
- Is there a role for OPAT in the management of patients with MRSA infections?
- Can we determine the appropriate duration of therapy for MRSA infections?
- What stewardship tactics can be applied to the management of MRSA infections?
- Can we differentiate among newer agents for MRSA bacteremia and endocarditis?
- How should clinicians manage MRSA bacteremia and infective endocarditis?
- How can primary care physicians manage community-associated MRSA pneumonia?
- What is the optimal treatment for MRSA nosocomial pneumonia?
- What are the therapeutic options for a complicated skin or skin structure MRSA infection?